UCLA Health Primary Care in Marina del Rey
Welcome,         Profile    Billing    Logout  
 12 Trials 
19 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Yee, Lisa D
TROFFi, NCT05595499: Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors

Recruiting
2
88
US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Fisetin, 3,3',4',7-Tetrahydroxyflavone, 7,3',4'-Flavon-3-ol, Placebo Administration, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration
Jonsson Comprehensive Cancer Center, National Cancer Institute (NCI), National Institute on Aging (NIA)
Anatomic Stage I Breast Cancer AJCC V8, Anatomic Stage II Breast Cancer AJCC V8, Anatomic Stage III Breast Cancer AJCC V8
06/26
06/26
NCT06538389: High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer

Recruiting
2
36
US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, BRC-001, Cannabidiol, CBD, CBD Oil, Placebo Administration, Questionnaire Administration
City of Hope Medical Center, National Cancer Institute (NCI), Biopharmaceutical Research Company
Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Breast Adenocarcinoma, Breast Ductal Carcinoma In Situ, Estrogen Receptor-Positive Breast Carcinoma, Progesterone Receptor-Positive Breast Carcinoma
08/26
08/26
NCT04821141: Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens

Recruiting
2
120
US
Bazedoxifene and Conjugated Estrogens, BZA+CE
University of Kansas Medical Center, National Cancer Institute (NCI)
Risk Reduction, Breast Cancer
07/26
07/27
NCT05941520: Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer

Recruiting
2
80
US
Acolbifene Hydrochloride, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Mammography, MG, Random Periareolar Fine-Needle Aspiration, Random Periareolar Fine Needle Aspiration, RPFNA, Tamoxifen, TMX
National Cancer Institute (NCI)
Breast Atypical Hyperplasia, Breast Carcinoma, Breast Ductal Carcinoma In Situ, Breast Lobular Carcinoma In Situ
08/27
09/28
NCT02831582: Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients With Stage I-III Breast Cancer

Completed
N/A
75
US
Omega-3 Fatty Acid, n-3 Fatty Acid, Omega 3 Fatty Acid, OMEGA-3 FATTY ACIDS, Omega-3 Polyunsaturated Fatty Acid, Omega-3 PUFA, omega-3-Fatty Acids, Placebo, placebo therapy, sham therapy
Ohio State University Comprehensive Cancer Center, National Cancer Institute (NCI)
Arthralgia, Breast Neoplasms
12/21
12/21
NCT04913064: Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer

Recruiting
N/A
26
US
Questionnaire Administration, White Button Mushroom Extract, WBM Extract
City of Hope Medical Center, National Cancer Institute (NCI)
Breast Carcinoma
01/26
01/26
NCT02295059: Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention

Active, not recruiting
N/A
80
US
omega 3 fatty acids, fish oil, eicosapentaenoic acid, docosahexaenoic acid
City of Hope Medical Center, National Cancer Institute (NCI)
Breast Cancer
12/24
12/24
NCT03865992: Curcumin in Reducing Joint Pain in Breast Cancer Survivors With Aromatase Inhibitor-Induced Joint Disease

Active, not recruiting
N/A
42
US
Curcumin, C.I. 75300, C.I. Natural Yellow 3, Diferuloylmethane, Turmeric Yellow, (E,E)-1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione, 32982, 458-37-7, Placebo, placebo therapy, PLCB, sham therapy, Nanoemulsion, Quality-of-Life Assessment, Quality of Life Assessment,, Questionnaire, Questionnaires
City of Hope Medical Center, National Cancer Institute (NCI)
Breast Cancer, Joint Pain
12/24
12/24
MiCHOICE, NCT04496739: Making Informed Choices on Incorporating Chemoprevention Into Care

Recruiting
N/A
415
US, RoW
Cancer Educational Materials, Decision Aid, Interview, Questionnaire Administration
SWOG Cancer Research Network, National Cancer Institute (NCI)
Atypical Hyperplasia of the Breast, Lobular Breast Carcinoma In Situ, Pleomorphic Lobular Breast Carcinoma In Situ
05/25
06/28
NCT03303846: Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer Patients

Active, not recruiting
N/A
344
US
Magnetic Resonance Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MRI, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, Biospecimen Collection, Laboratory Biomarker Analysis
City of Hope Medical Center, National Cancer Institute (NCI)
Healthy Subject
04/26
04/26
COMET, NCT02926911: Comparing an Operation to Monitoring, With or Without Endocrine Therapy () Trial For Low Risk DCIS

Active, not recruiting
N/A
997
US
Surgery, Active Monitoring
Alliance Foundation Trials, LLC., Patient-Centered Outcomes Research Institute, Duke University, Dana-Farber Cancer Institute, M.D. Anderson Cancer Center, New York University, Washington University School of Medicine
DCIS, Ductal Carcinoma in Situ
07/28
07/28
Sedrak, Mina
NCT00609791: Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients of Different Ages With Metastatic Breast Cancer

Active, not recruiting
2
40
US
paclitaxel albumin-stabilized nanoparticle formulation, pharmacological study, physiologic testing, questionnaire administration, study of socioeconomic and demographic variables, cognitive assessment, psychosocial assessment and care
City of Hope Medical Center, National Cancer Institute (NCI)
Breast Cancer
10/11
12/24
NCT01463072: Nab-Paclitaxel in Treating Older Patients With Locally Advanced or Metastatic Breast Cancer

Active, not recruiting
2
40
US
Laboratory Biomarker Analysis, Nab-paclitaxel, ABI 007, ABI-007, Abraxane, Albumin-bound Paclitaxel, Albumin-Stabilized Nanoparticle Paclitaxel, Nanoparticle Albumin-bound Paclitaxel, Nanoparticle Paclitaxel, Paclitaxel Albumin, paclitaxel albumin-stabilized nanoparticle formulation, protein-bound paclitaxel, Questionnaire Administration
City of Hope Medical Center, National Cancer Institute (NCI)
Locally Advanced Breast Carcinoma, Metastatic Breast Carcinoma, Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v7, Stage IIIA Breast Cancer AJCC v7, Stage IIIB Breast Cancer AJCC v7, Stage IIIC Breast Cancer AJCC v7, Stage IV Breast Cancer AJCC v6 and v7
05/17
12/24
NCT03633331: Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer

Active, not recruiting
2
93
US
Palbociclib, Letrozole, Fulvestrant, Questionnaire Administration, Quality-of-Life Assessment
Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI)
Estrogen Receptor-positive Breast Cancer, HER2/Neu Negative, Stage IV Breast Cancer AJCC v6 and v7
09/20
08/24
NCT03477396: Ribociclib and Aromatase Inhibitor in Treating Older Participants With Hormone Receptor Positive Metastatic Breast Cancer

Completed
2
2
US
Aromatase Inhibitor, Androstenedione Aromatase Inhibitor, Estrogen Synthase Inhibitor, Estrogen Synthetase Inhibitor, Laboratory Biomarker Analysis, Pharmacokinetic Study, PHARMACOKINETIC, PK Study, Questionnaire Administration, Ribociclib, Kisqali, LEE-011, LEE011
City of Hope Medical Center, National Cancer Institute (NCI)
Estrogen Receptor and/or Progesterone Receptor Positive, HER2/Neu Negative, Stage IV Breast Cancer AJCC v6 and v7
09/21
06/23
NCT04305834: Abemaciclib and Endocrine Therapy in Older Patients with Breast Cancer.

Recruiting
2
43
US
Abemaciclib, LY-2835219, LY2835219, Verzenio, Questionnaire Administration
City of Hope Medical Center, National Cancer Institute (NCI)
Anatomic Stage IV Breast Cancer AJCC V8, Hormone Receptor Positive Breast Carcinoma, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC V8
08/25
08/25
TROFFi, NCT05595499: Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors

Recruiting
2
88
US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Fisetin, 3,3',4',7-Tetrahydroxyflavone, 7,3',4'-Flavon-3-ol, Placebo Administration, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration
Jonsson Comprehensive Cancer Center, National Cancer Institute (NCI), National Institute on Aging (NIA)
Anatomic Stage I Breast Cancer AJCC V8, Anatomic Stage II Breast Cancer AJCC V8, Anatomic Stage III Breast Cancer AJCC V8
06/26
06/26
NCT06113016: Prevention of Frailty with Fisetin and Exercise (PROFFi) in Breast Cancer Survivors

Recruiting
2
164
US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Educational Intervention, Education for Intervention, Intervention by Education, Intervention through Education, Intervention, Educational, Exercise Intervention, Fisetin, 3,3',4',7-Tetrahydroxyflavone, 7,3',4'-Flavon-3-ol, Physical Performance Testing, Physical Fitness Testing, Physical Function Testing, Placebo Administration, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration
Jonsson Comprehensive Cancer Center, National Institutes of Health (NIH), National Cancer Institute (NCI)
Anatomic Stage I Breast Cancer American Joint Committee on Cancer (AJCC) V8, Anatomic Stage II Breast Cancer AJCC V8, Anatomic Stage III Breast Cancer AJCC V8, Early Stage Breast Carcinoma
08/28
08/31
NCT01472094: The Hurria Older PatiEnts (HOPE) With Breast Cancer Study

Active, not recruiting
N/A
700
US
City of Hope Medical Center, National Institutes of Health (NIH), National Institute on Aging (NIA)
Breast Cancer
12/18
12/24

Download Options